Target Price Playground
BMED
$35.93
Forward Projection
If price hits $40 by Jan 15
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Moderately bullish. Debit, capped max profit + loss.
๐ฏ Target
1-Click Institutional Target Anchors:
60d from today
โ๏ธ Legs
LONG CALL ยท $36 ยท Jan '27
Qty 1 ยท Premium $1.84 ยท ฮ 0.54
SHORT CALL ยท $39 ยท Jan '27
Qty 1 ยท Premium $0.75 ยท ฮ 0.29
P&L at Expiry
Stock (100 sh)
Bull Call Spread
Now
Target
๐ก Stock vs Options at Target
If BMED hits $40 by Jan 15: the bull call spread returns +$191 (175.5%) on $109 risked, vs +$431 (12.0%) for 100 shares on $3,593. Options give 14.6ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if BMED is at $40.
๐ Projected Return
P&L if BMED hits $40 by Jan 15
+$191
+175.5% on $109 risked
Max Profit
+$191
If the stock โฅ $39 at expiry
Max Loss
โ$109
Net debit
Break-even
$37.09
+3.23% from spot
Prob. of Profit at Expiry (PoP)
39.7%
Above breakeven ($37.09)
ยท Touch Target: 32%
30-Day Theta Burn (If Flat)
โ$9
8.3% of entry cost ยท Daily ฮ: $-0.3/day
Net ฮ / ฮ / V
25.17 / -0.3 / 0.79
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| BMED Price | Today | Dec 6 | Dec 26 | Jan 15 (exp) |
|---|---|---|---|---|
| $29 (-20%) | -$104 | -$108 | -$109 | -$109 |
| $31 (-15%) | -$94 | -$102 | -$108 | -$109 |
| $32 (-10%) | -$74 | -$87 | -$102 | -$109 |
| $34 (-5%) | -$42 | -$56 | -$78 | -$109 |
| $35 (-2%) | -$18 | -$29 | -$50 | -$109 |
| $36 (0%) โ spot | +$0 | -$8 | -$24 | -$109 |
| $37 (+2%) | +$18 | +$14 | +$5 | -$44 |
| $38 (+5%) | +$46 | +$48 | +$51 | +$64 |
| $40 (+10%) | +$89 | +$99 | +$119 | +$191 |
| $40 (+12%) โ target | +$104 | +$117 | +$140 | +$191 |
| $41 (+15%) | +$125 | +$139 | +$162 | +$191 |
| $43 (+20%) | +$150 | +$164 | +$182 | +$191 |
Uses BMED's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.